Literature DB >> 8494389

In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.

J M Koehler1, L R Ashdown.   

Abstract

Greater than 90% of 131 strains of Aeromonas species were susceptible to the aminoglycosides, ureidopenicillins, extended-spectrum cephalosporins, aztreonam, quinolones, tetracycline, and chloramphenicol, and all were uniformly resistant to ampicillin. Except for amoxicillin-clavulanate, sulfonamide, trimethoprim, and trimethoprim-sulfamethoxazole, there was good correlation between the results obtained by the agar dilution and disk diffusion techniques.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8494389      PMCID： PMC187809          DOI： 10.1128/AAC.37.4.905

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Aeromonas septicemia: relationship of species and clinical features.

Authors:  M Dryden; R Munro
Journal:  Pathology       Date:  1989-04       Impact factor: 5.306

2.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

3.  Infection due to Aeromonas hydrophila.

Authors:  K B Shilkin; D I Annear; L R Rowett; B H Laurence
Journal:  Med J Aust       Date:  1968-03-02       Impact factor: 7.738

4.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

5.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents.

Authors:  A Burgos; G Quindós; R Martínez; P Rojo; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

Review 7.  Media and methods for isolation of aeromonads from fecal specimens. A multilaboratory study.

Authors:  N P Moyer; H K Geiss; M Marinescu; A Rigby; J Robinson; M Altwegg
Journal:  Experientia       Date:  1991-05-15

8.  Antimicrobial susceptibility of Aeromonas hydrophila.

Authors:  T L Overman
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

9.  Resistance of Aeromonas hydrophila to beta-lactam antibiotics.

Authors:  R Zemelman; C Gonzalez; M A Mondaca; J Silva; C Merino; M Dominguez
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

10.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191
View more
  8 in total

1.  Antimicrobial susceptibilities of Aeromonas strains isolated from clinical and environmental sources to 26 antimicrobial agents.

Authors:  Max Aravena-Román; Timothy J J Inglis; Barbara Henderson; Thomas V Riley; Barbara J Chang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe.

Authors:  Patrick Hochedez; Emilie Hope-Rapp; Claude Olive; Muriel Nicolas; Gilles Beaucaire; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.

Authors:  Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

4.  Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.

Authors:  W C Ko; K W Yu; C Y Liu; C T Huang; H S Leu; Y C Chuang
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Which antibiotics and breakpoints should be used for Aeromonas susceptibility testing? Considerations from a comparison of agar dilution and disk diffusion methods using Enterobacteriaceae breakpoints.

Authors:  B Lamy; F Laurent; A Kodjo; F Roger; E Jumas-Bilak; H Marchandin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-27       Impact factor: 3.267

6.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy.

Authors:  W C Ko; H M Wu; T C Chang; J J Yan; J J Wu
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.

Authors:  Wen-Chien Ko; Shyh-Ren Chiang; Hsin-Chun Lee; Hung-Jen Tang; Yin-Yi Wang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.